Considerations on third generation antihistamines

Clinical and Experimental Allergy

Volumn 32, Issue 2, 2002, Pages 179-

  Holgate, S T ^a  

^a SOUTHAMPTON GENERAL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHISTAMINIC AGENT;

ALLERGY; ANTIINFLAMMATORY ACTIVITY; BLOOD BRAIN BARRIER; CARDIOTOXICITY; DRUG EFFECT; DRUG LABELING; DRUG METABOLISM; DRUG PENETRATION; DRUG POTENCY; EDITORIAL; HEALTH PRACTITIONER; MEDICAL LITERATURE; PRIORITY JOURNAL;

ALLERGY AND IMMUNOLOGY; HISTAMINE H1 ANTAGONISTS; HUMANS; TERMINOLOGY;

EID: 0036224844     PISSN: 09547894     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2222.2002.01339.x     Document Type: Editorial

References (5)

1. Second and third generation antihistamines
2. Therapeutic advantages of third generation antihistamines
3. New insights into the second generation antihistamines
4. Results of the treatment of children with pollinosis with the new non sedative Hi-blockers
5. Antihistamines: Back to the Future